Development Seed
Australis Scientific
Eurology
InConfidence Smart Patch Therapy; a once a week patch paired with a digital App to give personalized control of urinary symptoms. Making a personaly invasive in-clinic theraphy available descreetly at home.
Development Seed
Australis Scientific
Eurology
InConfidence Smart Patch Therapy; a once a week patch paired with a digital App to give personalized control of urinary symptoms. Making a personaly invasive in-clinic theraphy available descreetly at home.
Development Seed
Australis Scientific
Eurology
InConfidence Smart Patch Therapy; a once a week patch paired with a digital App to give personalized control of urinary symptoms. Making a personaly invasive in-clinic theraphy available descreetly at home.
Opportunity
Incontinence can affect everyone
40MM Americans
6MM Australians
22MM Japanese
80% of Patients aged 70 years suffer
Negative impact on Quality of Life
Solution
InConfidence Smart Patch Therapy; a once a week patch paired with a digital App to give personalized control of urinary symptoms.
426M
people worldwide affected by incontinence
$65B
Annual cost of incontinence in the U.S
70%
of people with incontinence never seek medical advice
426M
people worldwide affected by incontinence
$65B
Annual cost of incontinence in the U.S
70%
of people with incontinence never seek medical advice
426M
people worldwide affected by incontinence
$65B
Annual cost of incontinence in the U.S
70%
of people with incontinence never seek medical advice
ARTICLES
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Validose Secures $2M in Pre-Seed Funding to Solve Clinical Trial Medication Adherence
Feb 18, 2025
The platform is the first to combat non-adherence in clinical trials, a cause of 30% of failures...
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Validose Secures $2M in Pre-Seed Funding to Solve Clinical Trial Medication Adherence
Feb 18, 2025
The platform is the first to combat non-adherence in clinical trials, a cause of 30% of failures...
